Department of Justice January 30, 2014 – Federal Register Recent Federal Regulation Documents

Agency Information Collection Activities: Proposed Collection; Comments Requested: Federal Firearms License (FFL) RENEWAL Application
Document Number: 2014-01844
Type: Notice
Date: 2014-01-30
Agency: Department of Justice, Bureau of Alcohol, Tobacco, Firearms and Explosives
Ralph J. Chambers, M.D.; Decision and Order
Document Number: 2014-01797
Type: Notice
Date: 2014-01-30
Agency: Drug Enforcement Administration, Department of Justice
House of Medicine; Decision and Order
Document Number: 2014-01794
Type: Notice
Date: 2014-01-30
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Registration; Clinical Supplies Management, Inc.
Document Number: 2014-01788
Type: Notice
Date: 2014-01-30
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Registration; Halo Pharmaceutical, Inc.
Document Number: 2014-01785
Type: Notice
Date: 2014-01-30
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Registration; United States Pharmacopeial Convention
Document Number: 2014-01784
Type: Notice
Date: 2014-01-30
Agency: Drug Enforcement Administration, Department of Justice
Drug Enforcement Administration
Document Number: 2014-01782
Type: Notice
Date: 2014-01-30
Agency: Department of Justice
Controlled Substances: 2014 Proposed Aggregate Production Quota for Three Temporarily Controlled Synthetic Phenethylamines
Document Number: 2014-01778
Type: Notice
Date: 2014-01-30
Agency: Drug Enforcement Administration, Department of Justice
Three synthetic phenethylamines 2-(4-iodo-2,5- dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25I-NBOMe; 2C-I-NBOMe; 25I; Cimbi-5), 2-(4-chloro-2,5-dimethoxyphenyl)-N-(2- methoxybenzyl)ethanamine (25C-NBOMe; 2C-C-NBOMe; 25C; Cimbi-82), and 2- (4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25B-NBOMe; 2C-B-NBOMe; 25B; Cimbi-36) were temporarily placed in schedule I of the Controlled Substances Act (CSA) by a final order published by the Drug Enforcement Administration (DEA) on November 15, 2013 (78 FR 68716). This means that any manufacturer that wishes to manufacture 25I-NBOMe, 25C-NBOMe, or 25B-NBOMe after November 15, 2013, must be registered with the DEA and have obtained a manufacturing quota for 25I-NBOMe, 25C-NBOMe, or 25B-NBOMe pursuant to 21 CFR part 1303. The DEA cannot issue individual manufacturing quotas for 25I-NBOMe, 25C-NBOMe, or 25B- NBOMe unless and until it establishes an aggregate production quota. Therefore, this notice proposes a 2014 aggregate production quota for 25I-NBOMe, 25C-NBOMe, and 25B-NBOMe.
Importer of Controlled Substances; Notice of Registration; Cambrex Charles City, Inc.
Document Number: 2014-01707
Type: Notice
Date: 2014-01-30
Agency: Drug Enforcement Administration, Department of Justice
Office of the Attorney General; Amendment of Americans with Disabilities Act Title II and Title III Regulations to Implement ADA Amendments Act of 2008
Document Number: 2014-01668
Type: Proposed Rule
Date: 2014-01-30
Agency: Department of Justice
The Department of Justice (Department) is issuing this Notice of Proposed Rulemaking (NPRM) to amend its Americans with Disabilities Act (ADA) regulations in order to incorporate the statutory changes to the ADA set forth in the ADA Amendments Act of 2008 (ADA Amendments Act or the Act), which took effect on January 1, 2009. Congress enacted the ADA Amendments Act in order to revise the ADA definition of ``disability'' and to ensure that the definition is broadly construed and applied without extensive analysis. In this NPRM, the Department is proposing to add new sections to its title II and title III ADA regulations at 28 CFR parts 35 and 36, respectively, to provide detailed definitions of ``disability'' and to make consistent changes in other sections of the regulations. The ADA Amendments Act authorizes the Attorney General to issue regulations consistent with the Act that implement the definitions of ``disability'' in sections 3 and 4 of the Act, including the rules of construction set forth in section 3. The Department invites written comments from members of the public on this proposed rule.